title: Naftopidil improves locomotor activity and urinary frequency in rats with pelvic venous congestion.
abstract: The α1D/A receptor antagonist, naftopidil, inhibits micturition reflex by acting on various different sites. We examined the effects of naftopidil on bladder activity and changes in the induced urinary frequency using female rats with pelvic venous congestion (PC). Twenty-four female rats were divided into sham, PC, and PC/naftopidil groups. After anesthetizing rats in the PC and PC/naftopidil groups, the bilateral common iliac veins and uterine veins were ligated. Rats in the sham and PC groups were fed a standard diet, while rats in the PC/naftopidil group were fed diets containing 0.04% naftopidil. After 4 weeks of treatment, locomotor activity, urinary nitric oxide metabolites (NOx), continuous cystometry, and plasma monoamine measurements were performed. PC rats exhibited a decrease of locomotor activity, a shorter interval between bladder contractions on continuous cystometry, and decreased urinary NOx and plasma serotonin levels than the sham rats. The PC/naftopidil rats exhibited an increase of locomotor activity, a longer interval between bladder contractions, and increased urinary NOx and plasma serotonin levels. Therefore, naftopidil might improve bladder dysfunction induced by pelvic venous congestion due to several actions in the central nervous system and bladder tissue, as well as acting as an α1 blocker to cause pelvic venous dilation.
authors.affiliation: Southern Knights' Laboratory.
authors.forename: Kimio
authors.initials: K
authors.lastname: Sugaya
authors.forename: Saori
authors.initials: S
authors.lastname: Nishijima
authors.forename: Katsumi
authors.initials: K
authors.lastname: Kadekawa
authors.forename: Katsuhiro
authors.initials: K
authors.lastname: Ashitomi
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Ueda
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Yamamoto
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D015306:Biogenic Monoamines / Q000097:blood; D004195:Disease Models, Animal; D005260:Female; D006940:Hyperemia / Q000097:blood / Q000188:drug therapy / Q000378:metabolism*; D008124:Locomotion / Q000187:drug effects*; D009281:Naphthalenes / Q000494:pharmacology*; D009569:Nitric Oxide / Q000652:urine; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D014554:Urination / Q000187:drug effects*
chemical_list: D000317:Adrenergic alpha-Antagonists; D015306:Biogenic Monoamines; D009281:Naphthalenes; D010879:Piperazines; D009569:Nitric Oxide; C064357:naftopidil